Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Molecular Medicine Reports|April 4, 2019
Low‑frequency pulsed electromagnetic field inhibits RANKL‑induced osteoclastic differentiation in RAW264.7 cells by scavenging reactive oxygen speciesYing Pi, Haifeng Liang, Qiang Yu, et al.
Hepatology Communications|September 11, 2023
CD4+ T-cell subsets in autoimmune hepatitis: A reviewHaoran Chen, Zhongyu Han, Yiyue Fan, et al.
Kidney Diseases (Basel, Switzerland)|June 5, 2024
A Deep Insight into Ferroptosis in Renal Disease: Facts and PerspectivesZhongyu Han, Yuanke Luo, Haoran Chen, et al.
Frontiers in Medicine|September 10, 2021
Immunomodulatory Effects of Heme Oxygenase-1 in Kidney DiseaseYunlong Li, Kuai Ma, Zhongyu Han, et al.
Frontiers in Cell and Developmental Biology|March 12, 2026
Autophagy in ocular diseases: from mechanisms to therapeutic potentialQi Zhao, Yumeng Lin, Zhongyu Han, et al.
Frontiers in Immunology|July 31, 2025
Ferroptosis and bone health: bridging the gap between mechanisms and therapyRenyan Xiao, Zhongyu Han, Peng Jia, et al.
Biochemical and Biophysical Research Communications|November 19, 2016
Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca2+-calcineurin-NFATc1 signaling pathwayJie Zhang, Haixia Xu, Zhongyu Han, et al.
Cell Communication and Signaling : CCS|March 7, 2025
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disordersYuqi He, Yumeng Lin, Jinfeng Song, et al.
Frontiers in Immunology|November 25, 2024
Exploring mechanisms of skin aging: insights for clinical treatmentMeiqi Zhang, Yumeng Lin, Zhongyu Han, et al.
Frontiers in Cell and Developmental Biology|February 9, 2026
Ferroptosis and Alzheimer's disease: unraveling the molecular mechanisms and therapeutic opportunitiesYuan Fang, Zhongyu Han, Siming Yang, et al.
Pageof 8